MedTrace Logo

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2024-10-21

No results posted yet for this study

Summary

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Conditions

  • Macrophage Activation Syndrome
  • Still's Disease, Adult-Onset
  • Stills Disease, Juvenile-Onset

Interventions

OTHER

Chart review

Retrospective Chart Review

Sponsors & Collaborators

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Principal Investigators

  • Uwe Ullman, MD · Swedish Orphan Biovitrum AG Riehenring 182, 4058 Basel, Switzerland

Eligibility

Min Age
6 Months
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-27
Primary Completion
2024-09-26
Completion
2024-09-26

Countries

  • United States
  • Canada
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06405152 on ClinicalTrials.gov